Bausch Health Companies Inc Share Price Toronto S.E.
Equities
CA91911K1021
Pharmaceuticals
Sales 2024 * | 9.4B 12.9B 784B | Sales 2025 * | 9.67B 13.27B 807B | Capitalization | 2.58B 3.54B 215B |
---|---|---|---|---|---|
Net income 2024 * | 148M 203M 12.35B | Net income 2025 * | 389M 534M 32.46B | EV / Sales 2024 * | 2.45 x |
Net Debt 2024 * | 20.44B 28.05B 1,705B | Net Debt 2025 * | 19.09B 26.2B 1,593B | EV / Sales 2025 * | 2.24 x |
P/E ratio 2024 * |
20.9
x | P/E ratio 2025 * |
6.67
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.62% |
Latest transcript on Bausch Health Companies Inc
Managers | Title | Age | Since |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 24/22/24 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 01/08/01 |
John Paulson
CHM | Chairman | 68 | 01/17/01 |
Steven Miller
BRD | Director/Board Member | 35 | 17/21/17 |
1st Jan change | Capi. | |
---|---|---|
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.70% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |